TIA
BIIB icon

Tiemann Investment Advisors’s Biogen BIIB Stock Holding History

Tiemann Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-720
Closed -$205K – 184
2023
Q2 		$205K Hold
720
– – 0.1% 182
2023
Q1 		$200K Buy
+720
New +$199K 0.11% 187
2022
Q1 		– Sell
-850
Closed -$204K – 210
2021
Q4 		$204K Hold
850
– – 0.09% 222
2021
Q3 		$241K Sell
850
-50
-6% -$16.4K 0.11% 177
2021
Q2 		$312K Hold
900
– – 0.15% 153
2021
Q1 		$252K Sell
900
-25
-3% -$6.74K 0.13% 175
2020
Q4 		$226K Buy
925
+90
+11% +$23.2K 0.12% 182
2020
Q3 		$237K Buy
835
+58
+7% +$16.2K 0.15% 157
2020
Q2 		$208K Hold
777
– – 0.14% 170
2020
Q1 		$246K Buy
777
+25
+3% +$7.59K 0.21% 121
2019
Q4 		$223K Buy
+752
New +$209K 0.15% 164
2018
Q4 		– Sell
-627
Closed -$222K – 162
2018
Q3 		$222K Buy
+627
New +$216K 0.17% 161
2018
Q1 		– Sell
-637
Closed -$203K – 171
2017
Q4 		$203K Buy
+637
New +$204K 0.16% 167
2016
Q4 		– Sell
-867
Closed -$271K – 158
2016
Q3 		$271K Hold
867
– – 0.25% 124
2016
Q2 		$210K Hold
867
– – 0.2% 152
2016
Q1 		$226K Hold
867
– – 0.22% 140
2015
Q4 		$266K Sell
867
-100
-10% -$28.7K 0.27% 119
2015
Q3 		$282K Buy
967
+70
+8% +$23.1K 0.31% 115
2015
Q2 		$362K Buy
897
+38
+4% +$15.3K 0.37% 84
2015
Q1 		$363K Buy
859
+210
+32% +$82.8K 0.38% 84
2014
Q4 		$220K Hold
649
– – 0.24% 129
2014
Q3 		$215K Hold
649
– – 0.24% 133
2014
Q2 		$205K Sell
649
-60
-8% -$18.1K 0.23% 136
2014
Q1 		$217K Sell
709
-15
-2% -$4.76K 0.24% 133
2013
Q4 		$202K Buy
+724
New +$187K 0.24% 134

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tiemann Investment Advisors's BIIB Position: Q3 2023 in Review

Tiemann Investment Advisors sold out of Biogen (BIIB) in Q3 2023, closing a stake of 720 shares — an estimated $205K sold.

Tiemann Investment Advisors first reported a position in BIIB in Q4 2013 and held it in 25 quarters. The position peaked at $363K in Q1 2015. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Tiemann Investment Advisors reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Tiemann Investment Advisors sold 720 Biogen shares in Q3 2023, an estimated $205K.
  • Tiemann Investment Advisors first reported a position in Biogen in Q4 2013 and held it in 25 quarters.
  • Tiemann Investment Advisors's Biogen position peaked at $363K in Q1 2015.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Tiemann Investment Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.